---
title: "Integra Lifesciences (IART) Gets a Hold from BTIG"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290617309.md"
description: "BTIG analyst Ryan Zimmerman maintained a Hold rating on Integra Lifesciences (IART) in a recent report. The company's shares closed at $17.60. The broader analyst consensus for IART is also a Hold, with an average price target of $19.40."
datetime: "2026-06-23T21:39:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290617309.md)
  - [en](https://longbridge.com/en/news/290617309.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290617309.md)
generator: "portal-rs"
---

# Integra Lifesciences (IART) Gets a Hold from BTIG

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Integra Lifesciences. The company’s shares closed today at $17.60.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Zimmerman is a 2-star analyst with an average return of 0.7% and a 42.31% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Solventum Corporation, and Intuitive Surgical.

Currently, the analyst consensus on Integra Lifesciences is a Hold with an average price target of $19.40.

### Related Stocks

- [IART.US](https://longbridge.com/en/quote/IART.US.md)
- [GKOS.US](https://longbridge.com/en/quote/GKOS.US.md)
- [SOLV.US](https://longbridge.com/en/quote/SOLV.US.md)
- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)

## Related News & Research

- ["Musical Chairs", Rising Correlations And Bad Breadth: Why BTIG Sees Stocks Retesting Recent Lows](https://longbridge.com/en/news/297816067.md)
- [G-III Apparel Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/297643618.md)
- [These Analysts Boost Their Forecasts On GitLab After Better-Than-Expected Q2 Results](https://longbridge.com/en/news/297779855.md)
- [BTIG Keeps Their Buy Rating on Shift4 Payments (FOUR)](https://longbridge.com/en/news/297163377.md)
- [Royal London Asset Management Ltd. Sells 830 Shares of NVR, Inc. $NVR](https://longbridge.com/en/news/297628620.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**